Navigation Links
Aderans Research Presents at SID (Society of Investigative Dermatology)
Date:5/7/2010

Aderans Research Institute Inc. (ARI) this week presents an abstract at the prestigious Society of Investigative Dermatology (SID) at the society’s annual meeting in Atlanta.

Atlanta, GA (PRWEB) May 7, 2010 -- Aderans Research Institute Inc. (ARI) this week presents an abstract at the prestigious Society of Investigative Dermatology (SID) at the society’s annual meeting in Atlanta.

The abstract—entered in the “Hair and Cutaneous Development” category—concerns hair follicle formation from cultured cells, and summarizes research conducted by a group of ARI researchers, including ARI research scientist Arben Nace, Executive Vice President Ken Washenik M.D., Ph.D., and Kurt Stenn M.D., Vice President Research and Chief Scientific Officer.

Entitled, “Common mechanism of hair follicle formation from dissociated trichogenic epidermal and dermal cells,” the work investigates whether morphogenetic steps dissociated cells take to produce a hair follicle in a mouse are the same across all mammals. The study concludes, “that hair follicles form from dissociated cells in all mammals by one common, or universal, morphogenetic pathway.”

“This abstract covers important ground in our research into follicle formation and activity,” said Ken Washenik. “It is central to our efforts to develop a clinically viable answer to the challenge of hair regeneration.”

“Presenting at SID is always an honor,” added Kurt Stenn. “It lends a degree of credibility to your work and provides a level of exposure you won’t find anywhere else.”

The 2010 SID Annual Meeting takes place May 5-8 at the Hilton Atlanta Hotel in Atlanta, GA.

About the SID

The Society of Investigative Dermatology is one of the leading organizations devoted to cutaneous investigation. Its stated mission is “to advance and promote the sciences relevant to skin health and disease through education, advocacy, and scholarly exchange of scientific information.” The society produces the Journal of Investigative Dermatology (JID), the premier journal dedicated to basic and clinical research in cutaneous biology. Learn more at http://www.sidnet.org

About Aderans Research

Aderans Research is a pioneer in the research and development of safe, effective cell engineered products for hair regeneration. With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world’s largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI’s study outcomes will be released as studies unfold. To see ARI’s latest clinical updates, please visit http://www.aderansresearch.com/ari_clinicupdates.html

Additional information on ARI can be found at www.aderansresearch.com.

Learn more about Aderans Co., Ltd. At http://www.aderans.co.jp/e/company/

# # #

Read the full story at http://www.prweb.com/releases/Investigative/Dermatology/prweb3971924.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aderans Research Acquires Intercytex Assets
2. Aderans Research Treats One-Hundredth Subject in Clinical Study
3. Genetic Research Sheds Light on Chronic Pain
4. Latest Research Shows that Green Tea and Pomegranate are Helpful in Losing Weight after Menopause, according to Dr. Ershadi
5. More GPU Routines for Technical Research Now Available from Numerical Algorithms Group
6. U of T researchers crack splicing code, solve a mystery underlying biological complexity
7. PMH cancer researchers link ovarian hormone to breast stem cells growth
8. Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas
9. Researchers find future temperatures could exceed livable limits
10. Mayo Clinic researcher details next-era advances in use of scopes for cancer detection
11. Fear of Proactive Chat Unfounded According to Research by Bold Software
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aderans Research Presents at SID (Society of Investigative Dermatology) 
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Shamanic Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation ... and body, these individual customized retreats offer the winter-weary soul an excellent opportunity ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... provides an overview on laser diffraction analysis as a tool to characterize particle ... significance and potential to obtain improved results and novel scientific findings. It describes ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, ... a new informational post on robotic hair transplantation. San Francisco residents may be ... and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be used ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ARLINGTON, VA (PRWEB) , ... February 26, 2017 , ... ... Medicaid Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, ... work with PerformCARE to use behavioral health analytics to improve Medicaid population health management. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully ... tests and pathology services, announced today the acceptance of ... United States and Canadian Academy of ... San Antonio, Texas . ... the Company,s extensive experience in molecular thyroid testing, including ...
(Date:2/27/2017)... CAESAREA , Israel and TAMPA, Fla. ... Heart Ltd., an emerging medical device company focused ... undergoing cardiac procedures, applauds the members of the ... past week for their acknowledgement of the need ... (TAVR) surgery. "The statements shared by ...
(Date:2/27/2017)... Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... development company focused on tissue protection, repair and ... GtreeBNT Co., Ltd., received a positive response from ... trial design for RGN-137 to treat epidermolysis bullosa ... that incorporates Thymosin beta 4 ("Tß4") as the ...
Breaking Medicine Technology: